Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more
– Primary focus continues to be on upcoming results from ENLIGHTEN 1 Phase 3 extension study in 4Q 2024 and ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients in 1H 2025, as planned – – In...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.024 | -8.10810810811 | 0.296 | 0.3426 | 0.2546 | 850370 | 0.304204 | CS |
4 | 0.0102 | 3.8961038961 | 0.2618 | 0.344 | 0.2532 | 1287670 | 0.29104355 | CS |
12 | -5.958 | -95.6340288925 | 6.23 | 6.79 | 0.2532 | 2315830 | 0.69928467 | CS |
26 | -4.308 | -94.0611353712 | 4.58 | 6.79 | 0.2532 | 1294975 | 1.05940438 | CS |
52 | -8.208 | -96.7924528302 | 8.48 | 9.98 | 0.2532 | 505761 | 1.58598963 | CS |
156 | -20.728 | -98.7047619048 | 21 | 22 | 0.2532 | 379827 | 2.49411821 | CS |
260 | 0 | 0 | 0 | 0.3079 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.